HHS Accelerates Shift to Human-Based Research, Reduces Reliance on Animal Testing

• by Assistant Secretary for Public Affairs (ASPA)

• September 21, 2026

Intranasal EVs may slow Alzheimer's disease

Amniotic cell–derived extracellular vesicles improved cognition while reducing amyloid-beta accumulation and neuroinflammation in experimental models.

• by Andrea Surnit

• September 16, 2026

• 3 min

Microsporidial keratoconjunctivitis may mimic allergy

Molecular testing identified Encephalitozoon hellem in a 9-year-old orthokeratology lens wearer after conventional treatment failed.

• by Andrea Surnit

• September 16, 2026

• 4 min

FDA revises monitoring for SCLC therapy

Initial monitoring decreases from 22 to 24 hours to 6 to 8 hours from the start of the first 2 infusions.

• by Kathryn Wighton

• September 15, 2026

• 2 min